الابحاث

South Egypt Cancer Institute

Assiut University

Department of Pediatric Oncology
# Title Research Member Research Year
61 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute 		Prof. Heba Abdel-Razik Sayed Hussein 2018
62 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Shaimaa / Elsayyed Youssef / Ahmed 2018
63 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom 		Prof. Amany Mohamed Ali Ahmed 2018
64 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Prof. Heba Abdel-Razik Sayed Hussein 2018
65 Bloodstream Infections in Febrile Neutropenic
Pediatric Cancer Patients: Microbiological and
Sepsis Biomarkers Insight 		Dr. Khaled Fathy Riad Osman 2018
66 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Amira Mahmoud Mohammed Osman 2018
67 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Mahmoud Motaz Elzembely 2018
68 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Prof. Amany Mohamed Ali Ahmed 2018
69 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Dr. Khaled Fathy Riad Osman 2018
70 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines Dr. Khaled Fathy Riad Osman 2017